P-Selectin glycoprotein ligand-1 (PSGL-1) is a mucin-like glycoprotein expressed on the surface of leukocytes that serves as the major ligand for the selectin family of adhesion molecules and functions in leukocyte tethering and rolling on activated endothelium and platelets. Previous studies have implicated the highly conserved cytoplasmic domain of PSGL-1 in regulating outside-in signaling of integrin activation. However, molecules that physically and functionally interact with this domain are not completely defined. Using a yeast two-hybrid screen with the cytoplasmic domain of PSGL-1 as bait, a novel protein designated selectin ligand interactor cytoplasmic-1 (SLIC-1) was isolated. Computer-based homology search revealed that SLIC-1 was the human orthologue for the previously identified mouse sorting nexin 20. Direct interaction between SLIC-1 and PSGL-1 was specific as indicated by co-immunoprecipitation and motif mapping. Colocalization experiments demonstrated that SLIC-1 contains a Phox homology domain that binds phosphoinositides and targets the PSGL-1/SLIC-1 complex to endosomes. Deficiency in the murine homologue of SLIC-1 did not modulate PSGL-1-dependent signaling nor alter neutrophil adhesion through PSGL-1. We conclude that SLIC-1 serves as a sorting molecule that cycles PSGL-1 into endosomes with no impact on leukocyte recruitment.
Introduction
The initial tethering and rolling of leukocytes on activated endothelium and platelets is a key biological event mediated by P-selectin glycoprotein ligand-1 (PSGL-1), a mucin-like glycoprotein that functions as a unique high-affinity ligand for the selectin family of adhesion molecules (for reviews, see [1] [2] [3] [4] ). Structurally, PSGL-1 is a type I integral membrane protein consisting of an N-terminal selectin-binding domain followed by a region of multiple decameric repeats bearing O-linked glycans, a short transmembrane domain, and lastly a cytoplasmic tail [5] [6] [7] [8] [9] [10] . Comparison of human and murine PSGL-1 reveals that the 69-amino acid intracellular domain of PSGL-1 is highly conserved. While overall identity between human and murine PSGL-1 is 50%, their cytoplasmic domains share 76% identity.
Several important physiological functions have been linked to the cytoplasmic domain of PSGL-1. First, it transduces signals from activated PSGL-1 into the cytoplasm of leukocytes, leading to downstream events including tyrosine phosphorylation of intracellular proteins [11] , activation of integrin CD11b/CD18 [12] , and induction of IL-8 [13] . Second, it modulates the adhesive properties of leukocytes. Truncation of the intracellular domain of PSGL-1 results in impaired rolling of myeloid cells on P-selectin, presumably due to a loss of moesin-mediated association of PSGL-1 with the leukocyte cortical cytoskeleton [14] . Third, the cytoplasmic tail of PSGL-1 may contain determinants that target PSGL-1 to specific cell membrane domains. In resting leukocytes, PSGL-1 is restricted to the tips of microvilli, which facilitates its binding to selectins on other cells [15] [16] [17] . Despite the importance of these molecular and cellular functions mediated by the cytoplasmic domain of PSGL-1, the complete set of intracellular molecules that bind to the PSGL-1 cytoplasmic domain remain to be identified.
We report here on the isolation and initial characterization of a novel sorting nexin that specifically interacts with the cytoplasmic domain of PSGL-1, a protein we designate as SLIC-1 for selectin ligand interactor cytoplasmic-1. The sorting nexins are a family of trafficking molecules defined by the presence of a Phox homology (PX) domain (for recent reviews, see [18] [19] [20] ). Originally identified in the p40phox and the p47phox subunit of NADPH oxidase, the *120-amino acid PX domain has been subsequently recognized in a number of proteins including sorting nexins and signaling molecules such as phosphatidylinositol 3-kinase (PI 3-kinase) and cytokine-independent survival kinase (CISK) [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . The PX domain has also been characterized as a phosphoinositide-binding module that can localize both the host protein and a bound protein to the cell membrane or intracellular vesicles (for reviews, see [20, [34] [35] [36] ).
A database homology search revealed that SLIC-1 was a member of the sorting nexin family. SLIC-1 contained a functional phosphoinositol-binding PX domain and could redistribute PSGL-1 to endosomes in cells. Functional significance of deletion of the SLIC-1 homologue in mice revealed that it did not affect neutrophil recruitment to the inflamed endothelium, indicating that the lack of SLIC-1 was not sufficient to modulate PSGL-1 function in vivo. This is the first report of the interaction of PSGL-1 with a sorting nexin, providing new insight into the intracellular trafficking of PSGL-1.
Results

Isolation of SLIC-1
To identify proteins that interact with the cytoplasmic domain of PSGL-1, a yeast two-hybrid screen was carried out using the cytoplasmic domain of human PSGL-1 as bait and a cDNA library from human monocytic U-937 cells as prey. Two specific molecules were isolated, both of which were novel proteins. This study characterized one of these two proteins, which we named SLIC-1 for selectin ligand intracellular cytoplasmic-1. A partial cDNA sequence derived from the yeast two-hybrid screen was used to screen a lambda ZAPII U-937 cell cDNA library to identify a full-length coding sequence for SLIC-1 ( Fig. 1A ; GenBank accession no. AY302441). Northern blot analysis using a SLIC-1 cDNA probe revealed a 3-kb mRNA species present in various tissues of hematopoietic origin as well as liver, small intestine, placenta, and lung (Supporting Information Fig. S1 ).
The open reading frame in SLIC-1 cDNA encoded a protein of 316 amino acids with a predicted molecular weight of 36 kDa (Fig. 1A) . Amino acid analysis of SLIC-1 revealed a centrally located domain that was homologous to the PX domain (shaded amino acids in Fig. 1A ). In addition to the PX domain, SLIC-1 had a proline-rich N terminus containing three PXXP motifs (amino acids in bold in Fig. 1A ), which are potential SH3 domain-interacting motifs. The region C-terminal to the PX domain consisted of 128 amino acids and did not show homologies to any known motifs. Nucleotide sequence analyses by BLAST search revealed sequence homology to a murine protein called sorting nexin 20 (SNX20) and a human protein called SNX21/SNX-L (Fig. 1B) . SNX20 and SNX21/SNX-L were proteins identified in efforts to isolate new sorting nexins based on the homology of their PX domains [20, 37] . When aligned by BLAST program, SLIC-1 and SNX20 shared 77% identity and 84% homology, while SNX20 and SNX21/SNX-L shared 38% identity and 52% homology. The alignment results suggested that SNX20 is the mouse homologue of SLIC-1. Based on the mouse genomic sequence of SLIC-1 (Heather H. Shih, unpublished data), we cloned mouse SLIC-1 cDNA by RT-PCR using mRNA extracted from mouse monocytic WEHI cells and confirmed that the mouse homologue of SLIC-1 was indeed SNX20 (data not shown). Despite the structural similarities to sorting nexins, the functions for SNX20 or SNX21/SNX-L have not been defined.
Interaction of SLIC-1 with PSGL-1 in mammalian cells
To confirm that interaction of PSGL-1 and SLIC-1 as observed in yeast occurs in mammalian cells, these molecules were co-immunoprecipitated from COS cells cotransfected with plasmids encoding SLIC-1 and PSGL-1. Immunoprecipitation of transfected lysates was performed using a mouse monoclonal anti-human PSGL-1 antibody and a control mouse IgG. SLIC-1 was detected in the PSGL-1 immunocomplex but not in the control immunocomplex by Western analysis (bands indicated by arrows in lanes 1 and 2, top SLIC-1 blot; Fig. 2A) . In Western blots, PSGL-1 appears as a ladder of bands due to its extensive post-translational modification [38] . Note also that SLIC-1 runs higher on SDS-PAGE gel (slightly above the 43 kDa molecular weight marker) than its predicted molecular weight (36 kDa). The reason for this molecular weight shift remains unclear. These data demonstrated that PSGL-1 and SLIC-1 interact specifically in mammalian cells.
To confirm that the interaction was specific for the cytoplasmic domain of PSGL-1, plasmids encoding mutant PSGL-1 were constructed (Fig. 2B) . Two mutants were expressed: pMT-PSGLDCT lacked the cytoplasmic domain, whereas a control mutant pMTPSGL/L-SE CT contained the L-selectin cytoplasmic domain in place of the PSGL-1 cytoplasmic domain. The rationale for making the latter mutant was to test whether SLIC-1 specifically interacted with PSGL-1 among cell surface molecules that assume similar membrane localization. In resting leukocytes, both PSGL-1 and L-selectin localize to the tips of microvilli [15] [16] [17] [39] [40] [41] . Despite being expressed at similar levels as the wild-type PSGL-1 (lanes 3 and 4, PSGL-1 blots in Fig. 2A) , both PSGLDCT and PSGL/L-SE CT showed little association with SLIC-1 (lanes 3 and 4, top SLIC-1 blot in Fig. 2A ), demonstrating that the interaction of PSGL-1 with SLIC-1 was specifically mediated by the cytoplasmic domain of PSGL-1.
To map the SLIC-1 binding domain, a truncation mutant of PSGL-1 was made and tested in the coimmunoprecipitation assay. Deletion of the most C-terminal 42 amino acids (PSGL360; Fig. 2A Fig. 2A) , suggesting that the SLIC-1 binding domain is within the first 37 amino acids in the PSGL-1 cytoplasmic domain. It has been reported that the ezrin/radixin/moesin (ERM) proteins moesin and ezrin directly bind the cytoplasmic domain of PSGL-1 [42, 43] . The binding site has been mapped to a juxtamembrane region within PSGL360 comprising the amino acid sequence SRKGH and S348 (underlined amino acid sequence in Fig. 2B ) [43] . To investigate the relationship between ERM binding and SLIC-1 binding, mutant PSGL-1 on the background of PSGL360 was generated with the ERM binding sequence mutated (PSGL360D including SRKGH deletion and S348A mutation; Fig. 2A ) [44] . Interestingly, this mutant exhibited enhanced SLIC-1 binding activity compared to either wild-type PSGL-1 or PSGL360 (compare lane 9 to lanes 6 and 8, top SLIC-1 blot in Fig. 2A) , suggesting that the endogenous ERM proteins in COS cells might compete for SLIC-1 binding to the cytoplasmic domain of PSGL-1. We next sought to confirm the above results in an in vitro motif mapping experiment by peptide array analysis. Arrays of 12-amino acid peptides were directly synthesized onto cellulose membranes. The entire peptide array constituted overlapping amino acid sequences (i.e. differing by only one amino acid), spanning the PSGL-1 cytoplasmic domain. The array was probed with bacterially expressed and purified glutathione-S-transferase (GST)-SLIC-1 fusion protein for positive interactions. As shown in the top panel in Fig. 2C , peptides that showed positive interaction with GST-SLIC-1 comprised sequences from two regions of the PSGL-1 cytoplasmic domain: a transmembrane (TM) proximal motif (YPVRNYSPTEM) and a TM distal motif (SPGLTPEPREDREGDDLTLHSFLP). Interestingly, in the co-immunoprecipitation assay, PSGL360 bound SLIC-1 as avidly as wild type even though it spanned only the TM proximal motif. We also probed the peptide array with the PX domain of SLIC-1 fused C-terminally to GST (GST-PX SLIC ). This protein displayed the same binding profile as GST-SLIC-1, interacting with both the TM proximal motif (YPVRNYSPTEMV) and the TM distal motif (SPGLTPEPREDREGDDLTLHSF) in the PSGL-1 cytoplasmic domain (middle panel); the GST control did not show any binding to the peptide array (bottom panel, Fig. 2C ), demonstrating the specificity of the assay. To confirm the results from peptide array analysis, a BIACORE was used to assay SLIC-1 recognition of two synthesized peptides that showed positive binding to GST-SLIC-1 (HMYPVRNYSPTE, REDREGDDLTLH). Both peptides showed specific and saturable binding to GST-SLIC-1 (Supporting Information Fig. S2 ). Taken to- gether, these in vitro studies revealed that SLIC-1 bound PSGL-1 via its PX domain and two binding motifs in the cytoplasmic domain.
Localization of SLIC-1 to endosomes in COS cells
A number of PX domain-containing proteins including sorting nexins have been found to localize to the endosomal compartments of cells (e.g. [24, 33] ). Heterologous systems including COS cells have been employed to examine the subcellular localization of these proteins [21, 30] . When enhanced green fluorescent protein (EGFP)-SLIC-1 was expressed in COS cells, similar subcellular distribution was observed as in K562 cells. SLIC-1 was found to localize to cell membrane, cytosol, nucleus, and intracellular vesicles (green staining in Fig. 3A) . The basis for the nuclear localization was not clear since computer analysis did not predict any recognizable nuclear import sequence. The vesicular structures where SLIC-1 resided were reminiscent of the endosomal compartments of other PX domain-containing molecules including several sorting nexins (e.g. [21, 30] ). Two endosomal markers, early endosomal antigen-1 (EEA-1) and endocytosed transferrin, were used in colocalization experiments to confirm the endocytic nature of these vesicles. In both cases, SLIC-1 colocalized with EEA-1 ( Fig. 3A-C) or transferrin in endosomes ( Fig. 3D-F) . These results demonstrated that SLIC-1 localized to endosomes in cells.
The PX domain of SLIC-1 is a functional lipidbinding domain
The PX domain is capable of targeting its host protein to endosomes by binding to phospatidylinositol 3-phosphate [PtdIns(3)P], a phosphoinositol important to endosomal structure and function in resting cells. Alignment of the SLIC-1 PX domain with other PX domains revealed a high degree of preservation of conserved amino acids (Fig. 4A) , suggesting that the SLIC-1 PX domain would be a functional lipid-binding module. Bacterially expressed and purified GST-SLIC PX was used to examine its lipid-binding activities in an overlay assay. Positive interaction of the SLIC-1 PX domain with a subset of phospholipids was detected, which included PtdIns(3)P, phospatidylinositol 4-phosphate [PtdIns (4) Fig. 4C ). Weak interactions with PtdIns(3)P and PtdIns(3,4,5)P 3 were detected after long exposure on the lipid array (data not shown).
The crystal structure of p40phox bound to PtdIns(3)P has recently been solved and Arg58 in p40phox was shown to form the most extensive interaction with the bound phospholipid [45] . A single amino acid mutation to Gln at this position was reported to effect loss of phospholipid binding without affecting the overall fold of the protein. This residue was highly conserved throughout PX domain-containing proteins and was present as Arg116 in SLIC-1. This prompted us to produce a mutant GST-PX SLIC protein containing an analogous Arg-to-Gln mutation at this position (R116Q). This resulted in decreased binding activity to all phospholipids as compared to wild-type GST-PX SLIC (compare the right panel with the left panel in Fig. 4B and C, respectively), while the two proteins were expressed at similar levels ( Fig. 4D ). This result suggested that the PX domain of SLIC-1 used conserved mechanisms to bind phospholipids. 
Phospholipid binding is required for SLIC-1 localization to endosomes
Since the R116Q mutation decreased binding of the SLIC-1 PX domain to phospholipids in vitro, we asked whether this mutation in full-length SLIC-1 would alter subcellular targeting of SLIC-1 to endosomes in cells. A plasmid encoding EGFP-SLICR116Q was constructed and expressed in COS cells. Impressively, none of the COS cells expressing the mutant showed localization of this protein to endocytic vesicles, while plasma membrane and nuclear localization of SLIC-1 were not affected (bottom panel, Fig. 5A ). Compared to decreasing lipid binding in vitro (Fig. 4B, C) , the R116Q mutation manifested a more potent phenotype in cells, presumably due to the presence of limited amounts of phospholipids in the endosomal membranes in the cells. This SLIC-1 mutant was capable of specifically interacting with PSGL-1 in a co-immunoprecipitation assay (data not shown), indicating that this mutation did not disrupt the overall protein folding. We next examined whether the endosomal targeting of SLIC-1 was mediated through the binding of its PX domain to endogenous phospholipids in the endosomes. Since the production of PtdIns(3)P in endosomes in COS cells is controlled by PI 3-kinase, the effect of inhibiting PI 3-kinase activity on SLIC-1 subcellular distribution was subsequently examined. COS cells transfected with EGFP-SLIC-1-expressing plasmid were treated with the PI 3-kinase inhibitor Wortmannin for the indicated periods of time before they were fixed for analysis by fluorescent microscopy. As shown in Fig. 5B , in untreated cells, endosomal localization of SLIC-1 was observed in every EGFP-SLIC-1-expressing cell (arrowheads in 0-min panel; Fig. 5B ). After 30 min of Wortmannin treatment, SLIC-1 was no longer localized to the endosomes (disappearance of vesicles in 30-min and 40-min panels; Fig. 5B ), while the prominent Figure 4 . The PX domain of SLIC-1 is a phospholipid-binding module. (A) Sequences of PX domains from different proteins were aligned using the CLUSTAIW program. Most, moderately, and less conserved residues are shown in grey letters on black background, white letters on grey background, and black letters on light grey background, respectively. (B-D) Wild-type and R116Q mutant SLIC-1 PX domains fused C-terminally to GST were expressed and purified from E. coli. The levels of these proteins were examined on a Coomassie-stained SDS-PAGE gel (D). Their lipid binding activities were tested in lipid overlay assays using commercial lipid strips (B) or lipid arrays (C). The concentration of each lipid spot on the lipid strip was 100 pmol/spot. Concentrations of lipids used for spotting each lipid array were 100, 50, 25, 12.5, 6.3, 3.2, and 1.6 pmol/spot. LPA, lysophosphatidic acid; LPC, lysophosphocholine; S1P, sphingosine-1-phosphate; PE, phosphatidylethanolamine; PA, phosphatidic acid; PC, phosphatidylcholine; PS, phosphatidylserine; PI, phosphoinositide.
nuclear distribution was preserved in the EGFP-SLIC-1-expressing cells. Taken together, these results suggested that the PX domain targeted the endosomal localization of SLIC-1 by binding to endogenous PtdIns(3)P on endosomal membranes in COS cells.
Coexpression of SLIC-1 with PSGL-1 regulates subcellular distribution of PSGL-1
Since the mouse homologue of SLIC-1, SNX20, was classified as a bona fide sorting nexin, we tested whether SLIC-1 functioned as a sorting nexin to modulate the trafficking of PSGL-1. We expressed EGFP-SLIC-1 in CHO cells that constitutively expressed human PSGL-1 [46] and examined the subcellular localization of PSGL-1 by confocal microscopy following indirect immunofluorescent staining. Similar to untransfected cells or cells expressing EGFP protein (data not shown), PSGL-1 localized to the plasma membrane as well as the cytoplasm in cells transfected with EGFP-SLICRQ (Fig. 6Ad) . Expression of EGFP-SLIC-1 caused a striking redistribution of PSGL-1 to SLIC-1-residing endosomes (Fig. 6Aa, c) . When counted under the fluorescent microscope, 70% of EGFP-SLIC-1-expressing cells showed endosomal PSGL-1 staining (Fig. 6B, left bar) , while 10% of EGFP-SLIC116Q-expressing cells exhibited PSGL-1 staining in vesicles (Fig. 6B, right bar) . Importantly, only one or two PSGL-1-positive vesicles were observed in EGFP-SLIC116Q-expressing cells, while a large number of vesicles were found in EGFP-SLIC-1-expressing cells (Fig. 6Aa) . The targeting of PSGL-1 to the endosomes was dependent on a functional PX domain in SLIC-1, since coexpression of the SLICR116Q mutant with PSGL-1 abrogated its detection in the endosomes (Fig. 6Ad, 6B ). This was observed despite the fact that these two proteins were still capable of physical interaction in co-immunoprecipitation experiments (data not shown). Furthermore, expression of EGFP-SLIC-1 in a CHO cell line constitutively expressing a soluble form of PSGL-1 truncated after Ile316 (sPSGL) inhibited redistribution of sPSGL to the endosomes (data not shown). These results indicated that the interaction of SLIC-1 with the cytoplasmic domain of PSGL-1 resulted in altered subcellular localization of PSGL-1. Sorting nexins such as SNX1 are known to target cell surface proteins for lysosomal degradation. Although SLIC-1 caused extensive redistribution of PSGL-1 to endosomes, membrane expression of PSGL-1 remained unchanged when SLIC-1 was coexpressed, indicating that SLIC-1 did not enhance the degredation of PSGL-1 (Supporting Information  Fig. S3) . Moreover, the absence of the murine homologue of SLIC-1 in SNX20 knockout mice (see next paragraph in Results section) did not alter the membrane expression of PSGL-1 in leukocytes from bone marrow cells as determined by FACS analysis (Supporting Information Fig. S3 ).
Deletion of the murine homologue of SLIC-1, SNX20, does not affect PSGL-1-dependent signaling in murine neutrophils
In response to local inflammation, the endothelial walls of venules up-regulate E-selectin, which binds PSGL-1 among other sialylated ligands on leukocytes. This subsequently leads to the activation of integrins on the activated leukocytes. Because PSGL-1 is known to act as an adhesive signaling molecule in murine neutrophils, we tested whether the interaction between SLIC-1 and PSGL-1 might serve a signaling role during neutrophil recruitment to the inflamed endothelium. Specifically, we investigated whether neutrophil adhesion as a result of b2-integrin activation triggered via E-selectin ligation and membrane clustering of PSGL-1 was dependent on the presence of SLIC-1.
Mice deficient in SNX20, the murine homologue of human SLIC-1, were generated on the 129SvEvBrd background. Exons 2 and 3 of the SNX20 gene including the transcription initiation codon ATG were deleted (Supporting Information). These mice were overall normal and healthy. Our first attempt to determine a functional output of SLIC-1 was to employ mouse neutrophils deficient in SNX20 in a vascular mimetic flow chamber. To observe integrin activation stemming directly from E-selectin ligation under shear stress as previously reported [47] , we replicated the geometry of a post-capillary venule in a custom-made flow chamber. Neutrophils were isolated from murine bone marrow and perfused over an L cell monolayer expressing E-selectin and ICAM-1 (L-E/I). As shown in Fig. 7 , over time, an increasing portion of the wild-type neutrophils exhibited integrin activation as indicated by an increase in the fraction of adherent and arrested neutrophils. As compared to the wild-type neutrophils, SNX20 -/-neutrophils exhibited similar behavior under these experimental settings. Both the density of neutrophils recruited per unit area (Fig. 7A ) and the fraction of these captured neutrophils that converted to arrest (Fig. 7B, C) remained similar between SNX20-deficient and wild-type neutrophils. These results indicate that the absence of SNX20 is not sufficient to affect PSGL-1-dependent capture and signaling of neutrophil arrest on E-selectin and ICAM-1.
A hallmark of selectin-dependent arrest is the redistribution of surface PSGL-1 into large, high-density clusters [48] . Despite the lack of a clear role in selectindependent neutrophil activation and arrest, it is possible that SNX20 has a role in this surface redistribution. To investigate this possibility, we briefly labeled nonpermeabilized live murine neutrophils with antibody against PSGL-1, and imaged its distribution during neutrophil recruitment to the L-E/I monolayers. As shown in Fig. 8A , both wild-type and SNX20 -/-neutrophil PSGL-1 rapidly formed characteristic clusters during rolling interaction with L-E/I. Detailed analysis of the size and distribution of these high-density clusters revealed no difference in PSGL-1 topography (Fig. 8B-D) . Subsequent to neutrophil arrest, PSGL-1 is known to redistribute to the trailing uropod of neutrophils migrating and transmigrating on inflamed endothelial cells [42] . No difference in PSGL-1 redistribution to the uropod was observed between wild-type and SNX20 -/-neutrophils transmigrating through a murine bEND.3 endothelial monolayer stimulated with IL-1b (Supporting Information Fig. S4 ) [49] . Therefore the absence of SNX20 did not disrupt the surface redistribution of PSGL-1 on rolling, activated, or transmigrating neutrophils.
The use of primary and secondary antibodies to cross-link PSGL-1 on a neutrophil surface is known to mimic direct ligation of PSGL-1 by selectins and can induce downstream events including calcium flux, F-actin polymerization, and integrin activation and affinity maturation [50, 51] . To examine the potential participation of SNX20 in PSGL-1-dependent signaling, PSGL-1 was cross-linked on murine neutrophils loaded with the calcium-sensitive dye Fluo-4. Influx of calcium served as a sensitive indicator of neutrophil activation state, and would reveal any defects in PSGL-1-dependent activation in SNX20-deficient neutrophils. Compared to the antibody, calcium flux was up-regulated to a comparable level in both wild-type and SNX20 -/-neutrophils upon PSGL-1 cross-linking (Fig. 9) . Taken together, our functional assays using murine SNX20 -/- neutrophils reveal no defect in PSGL-1-dependent inflammatory signaling in neutrophils.
Discussion
The cytoplasmic domain of PSGL-1 is a highly conserved region that regulates the adhesion receptor's subcellular localization and immune functions. To date, the only proteins shown to directly interact with this region of PSGL-1 are the actin-binding proteins moesin and ezrin [42] . Here, we report the isolation and identification of a novel protein called SLIC-1 that directly binds to the cytoplasmic tail of PSGL-1. Several lines of evidence collectively confirm the interaction between SLIC-1 and PSGL-1. First, SLIC-1 was isolated from the yeast twohybrid screen via direct interaction with the cytoplasmic domain of PSGL-1. Second, a complex of PSGL-1 and SLIC-1 can be co-immunoprecipitated from cells overexpressing these proteins. Third, purified GST-SLIC-1 binds to peptides corresponding to sequences derived from the PSGL-1 cytoplasmic domain in the peptide array analysis. Fourth, PSGL-1 and SLIC-1 colocalize in CHO cells expressing these two proteins. We have attempted to characterize the in vivo functional interactions between these two proteins by deleting the murine homologue of SLIC-1, SNX20, from the mouse genome. However, the loss of SNX20 did not diminish the ability of PSGL-1 to mediate leukocyte tethering or rolling nor activation of cell arrest via b 2 -integrins. SLIC-1 belongs to the family of sorting nexins that all contain a phospholipid-binding domain called the PX domain. The mammalian sorting nexin family currently includes 31 members [50] . In general, sorting nexins are believed to play a role in subcellular membrane and protein trafficking [52, 53] . Several sorting nexins, including SNX1 and SNX2, have been defined as components of a mammalian retromer complex functioning in the retrieval of cargos from the endosomal system to the Golgi. However, the function of the majority of this protein family remains unclear. SLIC-1/ SNX20 belongs to a 13-member subgroup of sorting nexins that contain extra motifs outside the PX domain but with unclear functions [52] . This study demonstrates that SLIC-1 localizes to early endosomes, dependent on the phospholipid binding activity of its PX domain. Interaction of SLIC-1 with PSGL-1 leads to redistribution of PSGL-1 to endosomes. As an integral membrane receptor, the biogenesis of PSGL-1 involves post-translational modification in Golgi and post-Golgi sorting through endosomes to proper membrane location [54] . SLIC-1 may play a role in the post-Golgi trafficking of PSGL-1 by targeting PSGL-1 into sorting endosomes. Once SLIC-1 directs PSGL-1 to the proper location in the plasma membrane, it may subsequently "hand off" PSGL-1 to the ERM proteins for the anchorage of PSGL-1 in restricted cell membrane domains. The ERM proteins have been shown to actively modulate the cell membrane localization of PSGL-1 by directing its movement to the uropod in activated leukocytes through direct interaction with the PSGL-1 cytoplasmic domain. Intriguingly, SLIC-1 and ERM seem to compete for PSGL-1 binding since we have found that the SLIC-1 binding motifs in PSGL-1 are distinct from that of the ERM proteins, and mutating the ERM binding motif on PSGL-1 actually resulted in increased SLIC-1 binding, although this was not manifested in altered redistribution of PSGL-1 to the neutrophil uropod. It is worth further dissecting the mechanisms of PSGL-1 regulation by SLIC-1 and ERM in future work.
One function linked to several sorting nexins is the regulation of recycling and degradation of cell surface receptors. For example, SNX17 has been reported to promote the membrane recycling of LRP (LDL Receptorrelated Protein) by preventing the sorting of this receptor to lysosomes for degradation [55] . Our data does not support a role of SLIC-1 in the regulation of PSGL-1 recycling and/or degradation. Coexpression of SLIC-1 with PSGL-1 does not alter the steady-state levels of PSGL-1 and the deletion of mouse SLIC-1/SNX20 does not change PSGL-1 surface levels on leukocytes.
As PSGL-1-interacting proteins, the ERM proteins have been shown to function as adaptors to mediate PSGL-1 signaling by recruiting the tyrosine kinase Syk to activated PSGL-1 [56] . We examined a possible role for SLIC-1 to mediate downstream signaling events from PSGL-1 by using mice containing the deletion of the gene encoding the murine SLIC-1 homologue, SNX20. Our results suggest that SLIC-1 may not play a signaling role downstream from PSGL-1 during neutrophil recruitment to inflamed endothelium. SNX20-deficient neutrophils rolling on a selectin-expressing substrate or stimulated by direct cross-linking of PSGL-1 showed no defect in activation and adhesive function. It is possible that the function of SLIC-1 is restricted to the regulation of the intracellular trafficking of PSGL-1, while the ERM proteins take over PSGL-1 from SLIC-1 at the plasma membrane and regulate the signaling functions of PSGL-1. Alternatively, a defect in PSGL-1-mediated signaling caused by the lack of SNX20 may be masked by the presence of additional selectin ligands that allow normal selectin interaction following initial leukocyte tethering. A third possibility is that a homologous protein to SNX20 called SNX21/SNX-L may substitute for the function of SNX20 in the SNX20-deficient mice. Despite a vast number of reports on sorting nexins in recent years, gene deletion in mice has not been applied extensively to study sorting nexins, and up to date only three sorting nexins (i.e. SNX1, SNX2, and SNX13) have been deleted from the mouse genome [57, 58] .
Interestingly, the deletion of SNX1 or SNX2 alone did not lead to any phenotype, but deletion of both revealed their functions in cellular trafficking [57] . This demonstrates that homologous sorting nexins can have redundant roles in vivo and deletion of a single sorting nexin may not readily yield functional phenotypes. This report is reminiscent of our study where the deletion of SNX20 alone has failed to manifest any regulation of PSGL-1 functions. The function of the SNX20 homologue SNX21/SNX-L is largely unknown and so far we have not analyzed a possible interaction between SNX21 and PSGL-1. If they do interact, future attempts should be made to examine PSGL-1 signaling in SNX20/SNX21 doubly deficient mice.
In summary, we have identified a novel protein designated SLIC-1 that directly interacts with the cytoplasmic domain of PSGL-1 and targets PSGL-1 to endosomes in cells. The physiological functions of SLIC-1 could involve transport of newly synthesized PSGL-1 among intracellular compartments and/or specialized membrane domains. Future studies will attempt to isolate an antibody that recognizes endogenous SLIC-1, thereby providing a tool to directly track its redistribution during modulation of leukocyte and endothelial function in vivo. Deletion of the murine homologue of SLIC-1 failed to alter PSGL-1 signaling, suggesting that either SLIC-1 does not play a role in PSGL-1 signaling, or other SLIC-1 homologues such as SNX21/SNX-L can play a redundant role in PSGL-1 sorting and signaling.
Materials and methods
Yeast two-hybrid screen
To construct the bait vector, a DNA fragment encoding the cytoplasmic domain of human PSGL-1 (PSLcyt) was amplified by PCR with the forward primer 5 0 -ATA CTG AAT TCC GCC TCT CCC GCA AGG GCC ACA T-3 0 and the reverse primer 5 0 -ATA CAG GAT CCA GAG TGA GCT AAG GGA GGA AAG-3 0 and cloned into pEG202 using Eco RI and Bam HI restriction sites. This resulted in an in-frame insertion of DNA encoding the PSGL-1 cytoplasmic domain fused 3 0 to a cDNA encoding the DNA-binding protein LexA. The bait vector was transformed into the S. cerevisiae yeast reporter strain EGY48 carrying the pSH18-34 lacZ reporter plasmid. Yeast carrying the PSLcyt bait protein was subsequently transformed with amplified DNA of a U-937 cDNA library in the vector pJG4-5 and selected on CM/Ura -/His -/Tryp -/Leu -/X-Gal + plates in the presence of galactose and raffinose, which allowed galactose-dependent gene transcription of proteins encoded by the cDNA library. Leu + /LacZ + yeast clones were further tested to confirm the specificity of the two-hybrid interactions. Plasmids from clones that showed specific interactions were rescued and subjected to sequencing.
Full-length cDNA cloning
Sequence analysis of yeast two-hybrid clones was done at the DNA Sequencing Department at Wyeth. A partial cDNA sequence of SLIC-1 derived from the yeast two-hybrid screen was used to screen a lambda ZAPII U-937 cell cDNA library to obtain the full-length clone.
DNA constructs A 1.5-kB Sal I DNA fragment containing the entire SLIC-1 coding region was subcloned into the Sal I site of the pEDDC mammalian expression vector. A 950-bp fragment containing the SLIC-1 coding region was generated by PCR with the forward primer 5 0 -CGG GAT CCG GAT CCA TGG CAA GTC CAG AGC ACC-3 0 and the reverse primer 5 0 -CGG GAT CCT CAG TGC AGG TAT TCT CGC-3 0 and subcloned into the Bam HI site of pEGFP-C1 (Clontech). The pEGFP-SLICR116Q mutant was generated by overlapping PCR mutagenesis. The first round of PCR was carried out using primer pair I (primer A 5 0 -CGG GAT CCG GAT CCA TGG CAA GTC CAG AGC ACC-3 0 ; primer B 5 0 -GCG AAG TCG GAA TAT TGC CGT TCC AGG AC-3 0 ) and primer pair II (primer C 5 0 -GTC CTG GAA CGG CAA TAT TCC GAC TTC GC-3 0 ; primer D 5 0 -CGG GAT CCT CAG TGC AGG TAT TCT CGC-3 0 ). The two products from the first round of PCR were purified from an agarose gel and combined in a second round of PCR using primer pair III (primers A and D) to obtain full-length SLIC-1-encoding cDNA. The resulting DNA fragment was subcloned into the Bam HI site of pEGFP-C1. To generate the pGEX-3X construct encoding the PX domain of SLIC-1, a 450-bp fragment encoding the PX domain of SLIC-1 was generated by PCR with the forward primer 5 0 -CGG GAT CCT TCA GTA CTG GCA GAA CCA G-3 0 and the reverse primer 5 0 -CGG GAT CCT CAC ACG CGC AGC AGC AGC-3 0 and subcloned into the Bam HI site of pGEX-3X (Clonetech). To generate the pGEX-3X construct encoding the PXR116Q mutant PX domain of SLIC-1, mutant DNA was generated by PCR using the pEGFP-C1-SLICR116Q plasmid as template. The same primers as used to generate wild-type PX domain were used. The resulting PCR fragment was subcloned into the Bam HI site of pGEX-3X. PSGL-1 mutant constructs were generated by PCR and cloned into the Eco RI site of the pMT21 mammalian expression vector. To generate pMT-PSGL/L-SE CT , pMT-PSGL-1 was used as template in two consecutive PCR reactions using primers with sequences corresponding to DNA sequences encoding the cytoplasmic domain of L-selectin. A first round of PCR reaction was carried out using the forward primer 5 0 -ATC CAC TTT GCC TTT CTC TCC-3 0 (HS62) and the reverse primer 5 0 -ATA CTT CTC TTG GAT TTC TTG CCT TTT TTT AAT CTC CTG ACC GCC AGC ACC ACA GTG C-3 0 . The PCR product was gel purified and used as the template for a second round of PCR reaction using HS62 as the forward primer and the reverse primer 5 0 -CGG AAT TCG AAT TCT TAA TAT GGG TCA TTC ATA CTT CTC TTG GAT TTC TTG C-3 0 . The PCR product was subsequently cloned into the Eco RI site of pMT21. During this cloning, a mutant clone was generated that encoded a stop codon following two Arg residues immediately after the PSGL-1 transmembrane domain, which we named PSGLDCT mutant. To generate the pMT21-PSGL360 mutant, a PCR reaction was carried out using HS62 as the forward primer and the reverse primer 5 0 -CGG AAT TCG AAT TCT AAG GCA ACA GGG ATG AGA TGC-3 0 . To generate the PSGL360D mutant, a PCR reaction was carried out using HS62 as the forward primer and the reverse primer 5 0 -CGG AAT TCG AAT TCT AAG GCA ACA GGG ATG AGA TGC AGA CCA TCT CGG TGG GGG C-3 0 . The sequences of all cloned constructs were verified by DNA sequencing.
Cell culture and transient transfections COS M6 cells were maintained in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal bovine serum (Sigma), 2 mM glutamine, 200 U/mL penicillin and 200 U/ mL streptomycin. A CHO cell line stably expressing PSGL-1 was previously established [44] and maintained in MEMa medium containing 10% heat-inactivated and dialyzed fetal bovine serum, 1 mg/mL G418 (Invitrogen), 10 mM methotrexate (Sigma), 2 mM glutamine, 200 U/mL penicillin and 200 U/ mL streptomycin. K562 cells were obtained from ATCC and were maintained in Iscove's modified Dulbecco's medium containing 10% heat-inactivated FCS, 4 mM L-glutamine, 1.5 g/L sodium bicarbonate, 200 U/mL penicillin and 200 U/ mL streptomycin. WEHI cells were obtained from ATCC and were maintained in Dulbecco's modified Eagle's medium containing 10% FCS, 4 mM L-glutamine, 1.5 g/L sodium bicarbonate, 200 U/mL penicillin and 200 U/mL streptomycin. Transient transfection of COS M6 cells was carried out using LipofectAMINE2000 (Invitrogen) according to the manufacturer's directions. Transient transfection of K562 cells was carried out using the Tfx-50 reagent (Promega) according to the manufacturer's directions.
Co-immunoprecipitation of SLIC-1 and PSGL-1 COS cells transiently transfected with expression vectors encoding SLIC-1 and wild-type or mutant PSGL-1 were lysed in lysis buffer [50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 5 mM EDTA, 5 mM DTT, with dissolved protease inhibitor tablet (Roche) ]. Cell lysates were cleared by centrifugation and supernatants were collected. PSGL-1 immunoprecipitation was carried out using a mouse monoclonal anti-human PSGL-1 antibody (2G3) and protein -G-agarose beads (Amersham). Control immunoprecipitation was carried out using mouse IgG (Santa Cruz Biotechnology). Immunocomplexes collected on the protein G-agarose beads were separated on 10% SDS-PAGE gels and subsequently transferred to PVDF membranes (Bio-Rad). Standard Western blotting procedures were carried out. To detect SLIC-1, a rabbit anti-SLIC-1 antibody raised against purified GST-SLIC-1 protein was used. On Western blots, this antibody recognized overexpressed SLIC-1 in cell lysates but not endogenous SLIC-1. To detect PSGL-1, a mouse monoclonal anti-human PSGL-1 antibody (4H10) was used [59] . Protein detection was achieved using an ECL Western blotting kit (NEN).
Expression and purification of GST fusion proteins E. coli BL21 cells (Stratagene) were transformed with pGEX-3X encoding GST or pGEX-3X plasmids encoding full-length SLIC-1 and the wild-type or mutant SLIC-1 PX domain, respectively. After reaching a cell density of OD 600 *0. 
Peptide array analysis
Cellulose membranes modified with polyethylene glycol and Fmoc-protected amino acids were purchased from Abimed (Lagenfeld, Germany). Fmoc-protected b-alanine was purchased from Chem-Impex (Wood Dale, IL). The arrays were defined on the membranes by coupling an b-alanine spacer, and peptides were synthesized using standard DIC/HOBt coupling chemistry as described previously [60, 61] . Activated amino acids were spotted using an Abimed ASP 222 robot. Washing and deprotection steps were done manually and the peptides were N-terminally acetylated after the final synthesis cycle. Following peptide synthesis and side chain deprotection, the membranes were washed in methanol for 10 min and in blocker (1% casein in PBS) for 10 min, followed by a 10-min wash in PBS. The membranes were then incubated with 110 nM GST-SLIC-1 or GST-PX for 2 h at 4 C with gentle shaking. Control membranes were incubated with the same concentration of GST alone. The membranes were washed four times for 2 min in PBS at 4 C, and the remaining bound protein was transferred onto a single PVDF membrane using a semi-dry blotter. The PVDF membrane was washed in blocker for 20 min and then incubated with 0.25 lg/mL of HRPconjugated anti-GST antibody B14 (Santa Cruz) for 30 min followed by a 10-min wash with blocker and two 10-min washes with TBS. The protein was visualized using SuperSignal West reagent (Pierce) and a digital camera (AlphaInnotech FluorImager). Signal intensity reflects the amount of protein bound at each spot.
Lipid overlay assay
Lipid strips and arrays were purchased from Echelon. Each membrane was first blocked in blocking buffer [10 mM TrisHCl pH 8, 150 mM NaCl, 0.1% Tween-20, 3% fatty acid-free BSA (Sigma)] for 1 h at room temperature. The membrane was then incubated in blocking buffer containing each GST fusion protein at 3 lg/mL for 1 h at room temperature. After three washes with the blocking buffer, the membrane was probed with an anti-GST monoclonal antibody (Santa Cruz Biotechnology) followed by anti-mouse IgG-HRP (The Jackson Laboratories). The bound proteins were detected using ECL reagents (NEN). 
Generation of SLIC-1/SNX20 knockout mice
The murine homologue of human SLIC-1 was previously cloned and named SNX20. SNX20-deficient mice were designed at Wyeth Research and generated at Lexicon Genetics, Inc., from 129SvEv-Brd mice carrying a cre/loxP conditional knockout allele of the SNX20 gene. The cre recombination resulted in the deletion of exons 2 and 3, which included the transcription initiation codon ATG on exon 2. Detailed methods are included in the Supporting Information.
Neutrophil isolation
Mice in all experimental procedures were used in accordance with an approved animal care and use protocol (IACUC #11712). Mouse bone marrow was extracted from the femurs of SNX20 -/-and SvEv129 wild-type mice as described [62] . Briefly, bone marrow was collected from experimental mice and suspended in Hank's Balanced Salt Solution (HBSS). After destroying the red blood cells using hypotonic lysis, neutrophils were purified from the resulting leukocyte population by layering the lysates on top of a 62% percoll cushion and applying centrifugation at 1300 Â g. The resulting neutrophils were suspended in saline buffered with 30 mM HEPES (HEPES buffer) without calcium, and the concentration of cells was determined using an automated Coulter counter (Becton Dickinson).
Flow chamber
Vascular mimetic microfluidic flow chambers were employed in order to apply shear stress to murine neutrophils on a substrate of murine L cells transfected with E-selectin and ICAM-1 as described [49, 63] . Detailed methods describing how neutrophil arrest was imaged and quantified are included in the Supporting Information.
Real-time immunofluorescence
In the indicated flow chamber experiments, wild-type or SNX20 -/-neutrophils were incubated with 10 lg/mL rat antimouse PSGL-1 antibody (2PH-1; BD Biosciences) conjugated to PE, for 10 min at room temperature before infusion. The antibody did not block interaction between neutrophils and the L-E/I monolayer, allowing real-time imaging of PSGL-1 localization by a mercury lamp-equipped fluorescent videomicroscope with appropriate filters. PSGL-1 clusters on the neutrophils captured in the resulting image sequences were defined as continuous regions 2.5 standard deviations brighter than the whole-cell average. Sequences were analyzed for cluster size, number of clusters, and average cluster distance from the centroid, using a custom macro written for Image Pro Plus.
Detection of PSGL-1-dependent calcium flux
In order to detect early neutrophil activation due to crosslinking of PSGL-1, we employed flow cytometry to measure calcium flux. The average level of intracellular calcium in stimulated neutrophils was assayed using the calcium-sensitive dye Fluo-4. Neutrophils were incubated with 1 lM Fluo-4 AM in calcium-free HEPES buffer for 30 min at 37 C. After this loading step, the cells were pelleted and then resuspended in HEPES buffer containing 1.5 mM calcium to a concentration of 2 Â 10 6 neutrophils/mL. At this point, neutrophils were incubated with 40 lg/mL of either a primary anti-PSGL-1 antibody (2PH-1) or an isotype-matched rat IgG (Southern Biotech) on ice for 20 min. Neutrophils were then pelleted and resuspended in HEPES buffer containing 25 mg/mL of secondary goat anti-rat IgG (Southern Biotech) and 1.5 mM calcium, then incubated for 20 min on ice. PSGL-1 cross-linked and control samples were then warmed to 37 C for 1 min before sampling by flow cytometry. Certain samples were exposed to 5 nM MIP-1a at this point as a positive activation control. The FITC channel was recorded for all neutrophils after excitation on a FACScan single-laser cytometer over the course of 10 min at 37 C. Calcium flux was quantified as the fraction of neutrophils exhibiting Fluo-4 intensity two times greater than the average unstimulated neutrophils.
